EAGLE ASSET MANAGEMENT INC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$70,000
+14.8%
17,1610.0%0.00%
Q4 2021$61,000
-1.6%
17,1610.0%0.00%
Q3 2021$62,000
+26.5%
17,161
+51.7%
0.00%
Q2 2021$49,000
+6.5%
11,316
+0.1%
0.00%
Q1 2021$46,000
-29.2%
11,309
-30.9%
0.00%
Q4 2020$65,000
+32.7%
16,359
-10.4%
0.00%
Q3 2020$49,000
+53.1%
18,265
+52.2%
0.00%
Q2 2020$32,00012,0020.00%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,180,0004.34%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,535,727$11,056,0003.87%
Sargent Investment Group, LLC 3,596,250$15,680,0003.72%
Rubric Capital Management LP 9,500,000$41,420,0002.61%
PERKINS CAPITAL MANAGEMENT INC 541,783$2,362,0001.34%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$8,284,0001.14%
Venator Capital Management Ltd. 709,700$3,094,0001.05%
LEVEL FOUR FINANCIAL, LLC 120,000$523,0000.22%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$875,0000.19%
Brown Advisory Securities, LLC 275,000$1,199,0000.19%
View complete list of ANTARES PHARMA INC shareholders